Work

NQO1 is a determinant for cellular sensitivity to anti-tumor agent Napabucasin.

Year: 2020
Type: article
Abstract: ; in vitro assays showed that NAPA is a substrate for NQO1, which mediates the generation of ROS that leads to cell death. Furthermore, activation of an NQO1 transcription factor NRF2 by chemicals, including an FDA approved drug, can increase the NAPA cytotoxicity. Our findings suggest a potential use of NQO1 expression as a companion diagnostic test to identify patients in future NAPA trials and a combination strategy to expand the application of NAPA-based regimens for cancer therapy.
Language: English
Subfield: Toxicology
Open Access status: green
OpenAlex ID: W3033835713
FWCI: 0.628
Cites: 48
Cited by: 10
Related to: 9